We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
2276
DELISTED
Intersect ENT, Inc
XENT
| $476K | ﹤0.01% |
27,771
+759
| +3% | +$10.6K |
|
|
ALJ
2277
DELISTED
Alon USA Energy Inc
ALJ
| $474K | ﹤0.01% |
38,890
+1,210
| +3% | +$14.5K |
|
2278
Entravision Communication
EVC
$1.03B
| $468K | ﹤0.01% |
75,468
+2,757
| +4% | +$16K |
|
2279
NeoGenomics
NEO
$1.97B
| $468K | ﹤0.01% |
59,365
+1,674
| +3% | +$13.6K |
|
2280
Virtu Financial
VIRT
$5.11B
| $467K | ﹤0.01% |
27,490
+906
| +3% | +$15.7K |
|
2281
Citizens
CIA
$239M
| $466K | ﹤0.01% |
62,681
+1,438
| +2% | +$12.8K |
|
2282
Lifecore Biomedical
LFCR
$166M
| $463K | ﹤0.01% |
38,615
+5,660
| +17% | +$71.7K |
|
|
SSNI
2283
DELISTED
Silver Spring Networks, Inc.
SSNI
| $463K | ﹤0.01% |
41,044
+1,529
| +4% | +$18.8K |
|
|
DFRG
2284
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $462K | ﹤0.01% |
25,612
+808
| +3% | +$13.8K |
|
|
KEYW
2285
DELISTED
The KEYW Holding Corporation
KEYW
| $461K | ﹤0.01% |
48,823
+6,881
| +16% | +$71.1K |
|
|
VIA
2286
DELISTED
Viacom Inc. Class A
VIA
| $460K | ﹤0.01% |
9,427
+380
| +4% | +$17.1K |
|
2287
LSB Industries
LXU
$783M
| $459K | ﹤0.01% |
63,560
+22,284
| +54% | +$154K |
|
2288
Triumph Financial Inc
TFIN
$1.81B
| $456K | ﹤0.01% |
17,666
+1,378
| +8% | +$36.5K |
|
2289
Carriage Services
CSV
$641M
| $455K | ﹤0.01% |
16,766
+536
| +3% | +$14.4K |
|
2290
STAAR Surgical
STAA
$1.21B
| $454K | ﹤0.01% |
46,281
+1,772
| +4% | +$17.7K |
|
|
FSB
2291
DELISTED
Franklin Financial Network, Inc.
FSB
| $453K | ﹤0.01% |
11,692
+1,285
| +12% | +$50K |
|
2292
Ducommun
DCO
$2.71B
| $450K | ﹤0.01% |
15,619
+3,146
| +25% | +$91.7K |
|
|
FBNK
2293
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $450K | ﹤0.01% |
18,159
+632
| +4% | +$14.8K |
|
|
ABTX
2294
DELISTED
Allegiance Bancshares
ABTX
| $449K | ﹤0.01% |
12,059
+494
| +4% | +$17.4K |
|
|
TTPH
2295
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $449K | ﹤0.01% |
2,443
+317
| +15% | +$35.5K |
|
2296
Tejon Ranch
TRC
$456M
| $448K | ﹤0.01% |
21,074
+677
| +3% | +$15.3K |
|
2297
Century Communities
CCS
$1.91B
| $446K | ﹤0.01% |
17,572
+690
| +4% | +$16K |
|
|
DX
2298
Dynex Capital
DX
$3.15B
| $444K | ﹤0.01% |
20,889
+1,458
| +8% | +$29.8K |
|
2299
Ardelyx
ARDX
$1.22B
| $443K | ﹤0.01% |
35,051
+1,371
| +4% | +$18K |
|
|
FFWM
2300
DELISTED
First Foundation Inc
FFWM
| $443K | ﹤0.01% |
28,593
+1,135
| +4% | +$17.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.